ReviewOncoTargets and therapy2020
Optimal Management of First-Line Advanced Renal Cell Carcinoma: Focus on Pembrolizumab.
Abhay Singh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papertrialcites it
ReviewOncoTargets and therapy2020
Abhay Singh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.